BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38855588)

  • 1. Prognostic value of tumor-stroma ratio in clear cell renal cell carcinoma after surgery.
    Yuan C; Du Y; Li H; Xu C; Zhu W; Zhang Z; Zhao W; Li X
    Transl Androl Urol; 2024 May; 13(5):679-687. PubMed ID: 38855588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
    Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
    Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
    Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
    Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
    Zuo MN; DU YQ; Yu LP; Dai X; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
    Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
    Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
    Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
    J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
    Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
    BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
    Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
    Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
    Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
    Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.
    van Wagensveld L; Walker C; Hahn K; Sanders J; Kruitwagen R; van der Aa M; Sonke G; Rottenberg S; Van de Vijver K; Janowczyk A; Horlings H
    Res Sq; 2023 Nov; ():. PubMed ID: 38014112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
    Zhang Y; Liu Y; Qiu X; Yan B
    Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Efficacy of Tumor-Stroma Ratio in Women With Breast Cancer: A Meta-Analysis of Cohort Studies.
    Jiang P; Chen Y; Liu B
    Front Oncol; 2021; 11():731409. PubMed ID: 34976792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of tumor-stroma ratio in pseudomyxoma peritonei from the appendix].
    Ma R; Li XB; Yan FC; Lin YL; Li Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):240-246. PubMed ID: 32306005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma.
    Ren W; Zhang H; Cheng L; Zhang Y; Yang C; Nie L; Yang C; Yao P; Han J; Zhuo D
    BMC Surg; 2023 May; 23(1):117. PubMed ID: 37165423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma.
    Zheng Y; Bao L; Chen J; Pan Y; Wang Q; Chen L; Gao X
    Cancer Manag Res; 2019; 11():3869-3886. PubMed ID: 31118803
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
    Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
    BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
    Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
    EBioMedicine; 2024 Jun; 104():105152. PubMed ID: 38728838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
    Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
    ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment characteristics association with clinical outcome in patients with resected intestinal-type gastric cancer.
    Tian CF; Jing HY; Sinicrope FA; Wang JS; Gao BB; Sun XG; Yao ZG; Li LP; Saberzadeh-Ardestani B; Song W; Sha D
    Oncologist; 2024 Jun; ():. PubMed ID: 38907674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.